Takeda Raises Profit Forecast After 'Pandemic-Resistant' Q1
Aided By Chronic Portfolio
Japan’s largest pharma company says it has seen no impact on its financial results so far from the coronavirus pandemic, with continuing growth for mainstay drugs, and raises its profit forecasts for the fiscal year on favorable one-off factors.
